Literature DB >> 11157728

Endothelial cells inhibit flow-induced smooth muscle cell migration: role of plasminogen activator inhibitor-1.

E M Redmond1, J P Cullen, P A Cahill, J V Sitzmann, S Stefansson, D A Lawrence, S S Okada.   

Abstract

BACKGROUND: The endothelium may play a pivotal role in hemodynamic force-induced vascular remodeling. We investigated the role of endothelial cell (EC) plasminogen activator inhibitor-1 (PAI-1) in modulating flow-induced smooth muscle cell (SMC) migration. METHODS AND
RESULTS: Human SMCs cocultured with or without human ECs were exposed to static (0 mL/min) or flow (26 mL/min; shear stress 23 dyne/cm(2)) conditions for 24 hours in a perfused capillary culture system. SMC migration was then assessed with a Transwell migration assay. In the absence but not in the presence of ECs, pulsatile flow significantly increased the migration of SMCs (264+/-26%) compared with SMCs under static conditions, concomitant with a 3- and 4-fold increase in PAI-1 mRNA and protein, respectively, in cocultured ECs. In the presence of PAI-1-/- ECs, flow increased wild-type SMC migration (226+/-25%), an effect that was reversed by exogenous PAI-1. To determine whether the antimigratory activity of PAI-1 was dependent primarily on inhibition of PAs or its association with vitronectin, experiments were conducted with PAI-1R (a mutant PAI-1 that binds to vitronectin but does not inhibit PA) and PAI-1K (a mutant that inhibits PA but has reduced affinity for vitronectin). PAI-1R inhibited both basal and flow-induced migration, whereas PAI-1K inhibited flow-induced migration in the absence of any effect on baseline migration.
CONCLUSIONS: Flow-induced EC PAI-1 inhibits flow-induced SMC migration in vitro. EC PAI-1 expression may be one of the predominant mechanisms responsible for controlling the process of vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11157728     DOI: 10.1161/01.cir.103.4.597

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Fluid Mechanics, Arterial Disease, and Gene Expression.

Authors:  John M Tarbell; Zhong-Dong Shi; Jessilyn Dunn; Hanjoong Jo
Journal:  Annu Rev Fluid Mech       Date:  2014-01       Impact factor: 18.511

2.  Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblasts.

Authors:  Jianyong Zhong; Hai-Chun Yang; Valentina Kon; Agnes B Fogo; Daniel A Lawrence; Ji Ma
Journal:  Lab Invest       Date:  2014-03-31       Impact factor: 5.662

Review 3.  Modulation of glomerulosclerosis.

Authors:  Li-Jun Ma; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2007-09-08       Impact factor: 9.623

Review 4.  Biomechanical regulation of vascular smooth muscle cell functions: from in vitro to in vivo understanding.

Authors:  Juhui Qiu; Yiming Zheng; Jianjun Hu; Donghua Liao; Hans Gregersen; Xiaoyan Deng; Yubo Fan; Guixue Wang
Journal:  J R Soc Interface       Date:  2013-10-23       Impact factor: 4.118

5.  Effects of Caveolin-1-ERK1/2 pathway on endothelial cells and smooth muscle cells under shear stress.

Authors:  Lan Jia; Lihua Wang; Fang Wei; Chen Li; Zhe Wang; Haibo Yu; Haiyan Chen; Bo Wang; Aili Jiang
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-06

Review 6.  Shear stress and plaque development.

Authors:  Saurabh S Dhawan; Ravi P Avati Nanjundappa; Jonathan R Branch; W Robert Taylor; Arshed A Quyyumi; Hanjoong Jo; Michael C McDaniel; Jin Suo; Don Giddens; Habib Samady
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-04

7.  Antimetastatic potential of PAI-1-specific RNA aptamers.

Authors:  Charlene M Blake; Bruce A Sullenger; Daniel A Lawrence; Yolanda M Fortenberry
Journal:  Oligonucleotides       Date:  2009-06

8.  Endothelial injury induces vascular smooth muscle cell proliferation in highly localized regions of a direct contact co-culture system.

Authors:  Jeffrey G Jacot; Joyce Y Wong
Journal:  Cell Biochem Biophys       Date:  2008-09-03       Impact factor: 2.194

9.  MicroRNA 329 suppresses angiogenesis by targeting CD146.

Authors:  Ping Wang; Yongting Luo; Hongxia Duan; Shu Xing; Jianlin Zhang; Di Lu; Jing Feng; Dongling Yang; Lina Song; Xiyun Yan
Journal:  Mol Cell Biol       Date:  2013-07-22       Impact factor: 4.272

10.  Renal fibrosis: not just PAI-1 in the sky.

Authors:  Agnes B Fogo
Journal:  J Clin Invest       Date:  2003-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.